Isoniazid acetylation rate and development of antinuclear antibodies upon isoniazid treatment.
D000974:Antibodies, Antinuclear; D000917:Antibody Formation; D003168:Complement Fixation Tests; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000378:metabolism* / Q000627:therapeutic use; D008297:Male; D010597:Pharmacogenetics; D010641:Phenotype; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000378:metabolism*
D000974:Antibodies, Antinuclear; D007538:Isoniazid